Skip to main content
. 2021 Aug 20;22(16):8961. doi: 10.3390/ijms22168961

Table 1.

Preclinical evidence for CB2R-mediated modulations in epilepsy.

Modulation Approaches Seizure or Epilepsy Model Response References
- PTZ induced seizures in heterozygous and homozygous CB2 knockout mice Susceptibility [84]
- Handling-induced and spontaneous seizures Susceptibility [81]
2-Arachidonoylglycerol (2-AG) Kainate induced seizures in CB1R and CB2R double-knockout mice Suppressed excitatory [12]
CB2 agonist beta caryophyllene PTZ induced seizures in mice Anticonvulsant activity [85]
CB2 agonist beta caryophyllene Induced by kainic acid (KA) seizure in mice Decreased the seizure scores [85]
CB2 antagonist AM630 Kainate induced seizures in CB1R knockout mice Increased seizure susceptibility [80]
CB2 agonist AM1241 PTZ induced seizures in rats Increased seizure severity [86]
CB2 agonist HU-308 DMCM and PTZ induced seizures in rats No significant effect on seizure severity [80]
CB2R agonist JWH133 PTZ induced seizures in mice No significant effect on seizure severity [84]
CB2R antagonist SR144528 PTZ induced seizures in mice Increases seizure susceptibility [84]
CB1/2R mixed agonist WIN 55,212-2 DMCM and PTZ induced seizures in rats Anticonvulsant effects [80]